0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Radiotherapy

Buy Now

Californium-252 Isotope for 21st Century Radiotherapy (Hardcover, 1997 ed.) Loot Price: R1,519
Discovery Miles 15 190
Californium-252 Isotope for 21st Century Radiotherapy (Hardcover, 1997 ed.): J. G. Wierzbicki

Californium-252 Isotope for 21st Century Radiotherapy (Hardcover, 1997 ed.)

J. G. Wierzbicki

Series: NATO Science Partnership Subseries: 3, 29

 (sign in to rate)
Loot Price R1,519 Discovery Miles 15 190 | Repayment Terms: R142 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Californium-252 is a neutron emitter with a high specific activity, making it useful in a variety of applications, the most spectacular of which is in brachytherapy for cancer patients. Radiation oncology has exhausted nearly every option for treating radioresistant tumors by photon brachytherapy, and therefore new types of radiation need to be studied to improve the curability of cancer. Audience: Californium brachytherapy is used in only a few radiation therapy centers in the world, so the book will be highly instructive for radiation oncologists, medical physicists and radiobiologists. The nuclear techniques used in clinical applications may also interest nuclear physicists and engineers.

General

Imprint: Springer
Country of origin: Netherlands
Series: NATO Science Partnership Subseries: 3, 29
Release date: 2001
First published: 1997
Editors: J. G. Wierzbicki
Dimensions: 235 x 155mm (L x W)
Format: Hardcover
Pages: 300
Edition: 1997 ed.
ISBN-13: 978-0-7923-4543-5
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Radiotherapy
LSN: 0-7923-4543-6
Barcode: 9780792345435

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners